| Filing Date | Form | Description | Issuer | View |
|---|---|---|---|---|
| 8-K |
Report of unscheduled material events or corporate event |
Intellia Therapeutics, Inc. | ||
| 424B5 |
Form of prospectus disclosing information, facts, events covered in both forms 424B2, 424B3 |
Intellia Therapeutics, Inc. | ||
| 4 |
Statement of changes in beneficial ownership of securities |
Intellia Therapeutics, Inc. | ||
| 8-K |
Report of unscheduled material events or corporate event |
Intellia Therapeutics, Inc. | ||
| 10-Q |
Quarterly report which provides a continuing view of a company's financial position |
Intellia Therapeutics, Inc. | ||
| 3 |
Initial filing by director officer or owner of more than ten percent. |
Intellia Therapeutics, Inc. | ||
| 4 |
Statement of changes in beneficial ownership of securities |
Intellia Therapeutics, Inc. | ||
| DEF 14A |
Official notification to shareholders of matters to be brought to a vote ("Proxy") |
Intellia Therapeutics, Inc. | ||
| DEFA14A |
Additional proxy soliciting materials - definitive |
Intellia Therapeutics, Inc. | ||
| 8-K |
Report of unscheduled material events or corporate event |
Intellia Therapeutics, Inc. |
Displaying 311 - 320 of 590 results
Data provided by Kaleidoscope.